INHIBIDORES DE TGF-ß1 Y PRODUCTORES DE ENDOGLINA PARA SU USO EN EL TRATAMIENTO DE EPIDERMOLISIS BULLOSA
TGF- {beta} 1 inhibitors and endoglin producers for use in the treatment of epidermolysis bullosa. The present invention relates to a TGF- {beta} 1 pathway inhibiting drug and an endoglin stimulator or a pharmaceutical composition thereof, for use in the treatment of genodermatosis, such as epidermolysis bullosa (EB). (Machine-translation by Google Translate, not legally binding).
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 08. Mai Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SÁNCHEZ-PUELLES GONZÁLEZ-CARVAJAL JOSÉ MARÍA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-05-08, Last update posted on www.tib.eu: 2022-05-02, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
ES2759400 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004229967 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004229967 | ||
| 003 | DE-627 | ||
| 005 | 20230504131907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA004229967 | ||
| 035 | |a (EPA)ES2759400 | ||
| 035 | |a (EPA)70483298 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SÁNCHEZ-PUELLES GONZÁLEZ-CARVAJAL JOSÉ MARÍA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INHIBIDORES DE TGF-ß1 Y PRODUCTORES DE ENDOGLINA PARA SU USO EN EL TRATAMIENTO DE EPIDERMOLISIS BULLOSA |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-05-08, Last update posted on www.tib.eu: 2022-05-02, Last updated: 2023-02-09 | ||
| 520 | |a TGF- {beta} 1 inhibitors and endoglin producers for use in the treatment of epidermolysis bullosa. The present invention relates to a TGF- {beta} 1 pathway inhibiting drug and an endoglin stimulator or a pharmaceutical composition thereof, for use in the treatment of genodermatosis, such as epidermolysis bullosa (EB). (Machine-translation by Google Translate, not legally binding) | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BOTELLA CUBELLS LUISA MARÍA |4 aut | |
| 700 | 0 | |a AGUADO SÁNCHEZ TANIA |4 aut | |
| 700 | 0 | |a DEL RÍO NECHAEVSKY MARCELA |4 aut | |
| 700 | 0 | |a GARCÍA MARTÍN ADELA |4 aut | |
| 700 | 0 | |a GARCÍA DIEZ MARTA |4 aut | |
| 700 | 0 | |a LARCHER LAGUZZI FERNANDO |4 aut | |
| 700 | 0 | |a CARRETERO TRILLO MARTA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 08. Mai |
| 773 | 1 | 8 | |g year:2020 |g day:08 |g month:05 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/70483298/publication/ES2759400A1?q=ES2759400 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 08 |c 05 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 08 |c 05 | ||